http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2063955-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3899a93c972ce60b070fca823112248 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate | 1992-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_885ff0ba38a8a9d7f0b231d26cffe4a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ae07d8b505602dba02bcd2be0cc1b00 |
publicationDate | 2002-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2063955-C |
titleOfInvention | Pyrrolo(1,2-a)indole hydroxylamine derivatives as inhibitors of leukotriene biosynthesis |
abstract | Compounds having the formula I: <SEE FORMULA I> are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis and allograft rejection and in preventing the formation of athexosclerotic plaques. |
priorityDate | 1991-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 496.